A recent study suggested that SFRP2 promotes transition of glioblastoma to a mesenchymal subtype by suppressing SOX2,39 while another research found that SOX2 directly binds to the promoter of SFRP2, devoting to migration and invasion of CRC cells.40 The gene discussed is SFRP2; the disease is colorectal carcinoma.